These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 33546417)

  • 1. Inflammation-Related Changes in Mood Disorders and the Immunomodulatory Role of Lithium.
    Sakrajda K; Szczepankiewicz A
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33546417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflamed moods: a review of the interactions between inflammation and mood disorders.
    Rosenblat JD; Cha DS; Mansur RB; McIntyre RS
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Aug; 53():23-34. PubMed ID: 24468642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidepressant drugs and cytokines in mood disorders.
    Nishida A; Hisaoka K; Zensho H; Uchitomi Y; Morinobu S; Yamawaki S
    Int Immunopharmacol; 2002 Nov; 2(12):1619-26. PubMed ID: 12469936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory Mediators in Mood Disorders: Therapeutic Opportunities.
    Pfau ML; Ménard C; Russo SJ
    Annu Rev Pharmacol Toxicol; 2018 Jan; 58():411-428. PubMed ID: 28992428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mood Disorders, Accelerated Aging, and Inflammation: Is the Link Hidden in Telomeres?
    Squassina A; Pisanu C; Vanni R
    Cells; 2019 Jan; 8(1):. PubMed ID: 30650526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitigation of Inflammation-Induced Mood Dysregulation by Long-Chain Omega-3 Fatty Acids.
    McNamara RK
    J Am Coll Nutr; 2015; 34 Suppl 1(0 1):48-55. PubMed ID: 26400435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune-based strategies for mood disorders: facts and challenges.
    Colpo GD; Leboyer M; Dantzer R; Trivedi MH; Teixeira AL
    Expert Rev Neurother; 2018 Feb; 18(2):139-152. PubMed ID: 29179585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lithium for maintenance treatment of mood disorders.
    Burgess S; Geddes J; Hawton K; Townsend E; Jamison K; Goodwin G
    Cochrane Database Syst Rev; 2001; (3):CD003013. PubMed ID: 11687035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Guidelines for the prescription of mood stabilizers for adolescents: A literature review].
    Munch G; Godart N
    Encephale; 2017 Oct; 43(5):464-470. PubMed ID: 27871720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Compensatory Immune-Regulatory Reflex System (CIRS) in Depression and Bipolar Disorder.
    Maes M; Carvalho AF
    Mol Neurobiol; 2018 Dec; 55(12):8885-8903. PubMed ID: 29611101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resolution of inflammation and mood disorders.
    Chistyakov DV; Astakhova AA; Sergeeva MG
    Exp Mol Pathol; 2018 Oct; 105(2):190-201. PubMed ID: 30098318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of glial cell line-derived neurotrophic factor as a biomarker for mood disorders and lithium response.
    Idemoto K; Niitsu T; Hata T; Ishima T; Yoshida S; Hattori K; Horai T; Otsuka I; Yamamori H; Toda S; Kameno Y; Ota K; Oda Y; Kimura A; Hashimoto T; Mori N; Kikuchi M; Minabe Y; Hashimoto R; Hishimoto A; Nakagome K; Hashimoto K; Iyo M
    Psychiatry Res; 2021 Jul; 301():113967. PubMed ID: 33990070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trace lithium in mood disorders.
    Dafflon M; Décosterd LA; Biollaz J; Preisig M; Dufour H; Buclin T
    J Affect Disord; 1999 Jul; 54(1-2):199-203. PubMed ID: 10403165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral, immunomodulatory, and neuroprotective effect of lithium.
    Rybakowski JK
    J Integr Neurosci; 2022 Mar; 21(2):68. PubMed ID: 35364656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-HT1B receptors: a novel target for lithium. Possible involvement in mood disorders.
    Massot O; Rousselle JC; Fillion MP; Januel D; Plantefol M; Fillion G
    Neuropsychopharmacology; 1999 Oct; 21(4):530-41. PubMed ID: 10481837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common Environmental Factors May Underpin the Comorbidity Between Generalized Anxiety Disorder and Mood Disorders Via Activated Nitro-oxidative Pathways.
    Roomruangwong C; Simeonova DS; Stoyanov DS; Anderson G; Carvalho A; Maes M
    Curr Top Med Chem; 2018; 18(19):1621-1640. PubMed ID: 30430941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mood disorders: treatment-induced changes in brain neurochemistry and structure.
    Glitz DA; Manji HK; Moore GJ
    Semin Clin Neuropsychiatry; 2002 Oct; 7(4):269-80. PubMed ID: 12382209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Search for a common mechanism of mood stabilizers.
    Harwood AJ; Agam G
    Biochem Pharmacol; 2003 Jul; 66(2):179-89. PubMed ID: 12826261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of lithium on cytokine neuro-inflammatory mediators, Wnt/β-catenin signaling and microglial activation in the hippocampus of chronic mild stress-exposed rats.
    Habib MZ; Ebeid MA; El Faramawy Y; Saad SST; El Magdoub HM; Attia AA; Aboul-Fotouh S; Abdel-Tawab AM
    Toxicol Appl Pharmacol; 2020 Jul; 399():115073. PubMed ID: 32454056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.